Assessment of hearing dysfunction in patients with Graves’ disease and thyroid eye disease without or with teprotumumab

Published: 20 August 2024| Version 1 | DOI: 10.17632/772vxh6fyf.1
Contributor:
Terry Smith

Description

SUPPLEMENT Assessment of hearing dysfunction in patients with Graves’ disease and thyroid eye disease without or with teprotumumab

Files

Institutions

  • University of Michigan

Categories

Adverse Event, Hearing Loss

Licence